Literature DB >> 7065130

Glucose and alanine inhibition of phosphate transport in renal microvillus membrane vesicles.

P Q Barrett, P S Aronson.   

Abstract

Transport interactions among phosphate, glucose, and alanine were evaluated in brush border membrane vesicles isolated from the rabbit renal cortex. Both glucose and alanine inhibited the Na+ gradient-stimulated uphill accumulation of phosphate. Neither glucose nor alanine inhibited the phosphate uptake measured in the absence of Na+ or in the presence of a collapsed Na+ gradient shunted with amphotericin B. Phosphate and alanine inhibited the Na+ gradient-stimulated uphill accumulation of glucose but not the glucose uptake measured in the presence of a collapsed Na+ gradient shunted with amphotericin B. Alanine, which was more potent than glucose or phosphate in inhibiting Na+ gradient-stimulated solute transport, was also more potent than glucose or phosphate in stimulating the uptake of Na+ into the vesicles. We conclude that the inhibitory interactions among phosphate, glucose, and alanine probably represent indirect effects resulting from solute-induced alterations in the transmembrane electrochemical Na+ gradient rather than direct effects resulting from competition for a polyfunctional carrier or from allosteric interactions. Such a mechanism could explain the inhibitory interactions among phosphate, glucose, and alanine that have been observed in the intact proximal tubule.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065130     DOI: 10.1152/ajprenal.1982.242.2.F126

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Membrane transport in the proximal tubule and thick ascending limb of Henle's loop: mechanisms and their alterations.

Authors:  H Murer; R Greger
Journal:  Klin Wochenschr       Date:  1982-09-15

2.  Sodium-hydrogen exchange and glucose transport in renal microvillus membrane vesicles from rats with diabetes mellitus.

Authors:  R C Harris; B M Brenner; J L Seifter
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients-Cardiologists Be Aware.

Authors:  Anna Kurpas; Karolina Supel; Paulina Wieczorkiewicz; Joanna Bodalska Duleba; Marzenna Zielinska
Journal:  Metabolites       Date:  2022-05-30

4.  The influence of intracellular sodium activity on the transport of glucose in proximal tubule of frog kidney.

Authors:  F Lang; G Messner; W Wang; M Paulmichl; H Oberleithner; P Deetjen
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

5.  Electrophysiological analysis of Na+/Pi cotransport mediated by a transporter cloned from rat kidney and expressed in Xenopus oocytes.

Authors:  A Busch; S Waldegger; T Herzer; J Biber; D Markovich; G Hayes; H Murer; F Lang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Transport of L-lysine by rat renal brush border membrane vesicles.

Authors:  B Stieger; G Stange; J Biber; H Murer
Journal:  Pflugers Arch       Date:  1983-04       Impact factor: 3.657

Review 7.  Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences.

Authors:  Jessica A Dominguez Rieg; Jianxiang Xue; Timo Rieg
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-09       Impact factor: 2.894

8.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

Review 9.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: its relevance to the pathogenesis of diabetic retinopathy.

Authors:  H Vorum; J Ditzel
Journal:  J Ophthalmol       Date:  2014-03-20       Impact factor: 1.909

10.  Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus.

Authors:  Joanna Sophia J Vinke; Hiddo J L Heerspink; Martin H de Borst
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.